(Q73867001)
Statements
Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group (English)
Fogelman I
Ribot C
Smith R
Ethgen D
Sod E